Podcast Episodes

Back to Search
Bayer Layoffs, a Big Alzheimer’s Deal and ASGCT Wrap
Bayer Layoffs, a Big Alzheimer’s Deal and ASGCT Wrap

Bayer made news this week announcing 1,500 layoffs as part of an effort to save €500 million ($540 million) in 2024 and €2 billion ($2.16 billion) in…

2 years, 1 month ago

Short Long
View Episode
Women's Health: Where Politics and Science Meet
Women's Health: Where Politics and Science Meet

12 billion dollars: one of the boldest women’s health research moves an administration has made for women’s health research. On a global scale, this …

2 years, 2 months ago

Short Long
View Episode
ASGCT, Adcomm for Lilly’s Donanemab, Vertex Vs. Bluebird
ASGCT, Adcomm for Lilly’s Donanemab, Vertex Vs. Bluebird

In this edition of The Weekly, Managing Editor Jef Akst and News Editor Greg Slabodkin share their insights from the American Society of Gene & Cell …

2 years, 2 months ago

Short Long
View Episode
BioSpace Heads to #ASGCT, Along with Thousands in Cell and Gene Therapy
BioSpace Heads to #ASGCT, Along with Thousands in Cell and Gene Therapy

In this special edition of The Weekly, we discuss the much-anticipated annual meeting of the American Society of Gene & Cell Therapy in Baltimore. It…

2 years, 2 months ago

Short Long
View Episode
The IRA, BMS’ Big Cuts, First WHIM Approval
The IRA, BMS’ Big Cuts, First WHIM Approval

J&J and BMS’ challenges to Medicare drug price negotiations shut down in federal court less than a week after BMS announced it was laying off more th…

2 years, 2 months ago

Short Long
View Episode
Where Do We Go From Here? The Future of Women's Health
Where Do We Go From Here? The Future of Women's Health

The potential impacts on clinical trial outcomes warrant a discussion surrounding the current definition of women’s health.

In the second episode on…

2 years, 2 months ago

Short Long
View Episode
Sanofi Layoffs, CAR-T Warnings and a New GLP-1 Player
Sanofi Layoffs, CAR-T Warnings and a New GLP-1 Player

Sanofi will cut an undisclosed number of jobs as it revamps its U.S. vaccines commercial operations, as well as 99 employees from its Belgian sites—m…

2 years, 2 months ago

Short Long
View Episode
Amylyx and ALS, Continued ADC Excitement, Dire Drug Shortages
Amylyx and ALS, Continued ADC Excitement, Dire Drug Shortages

The past two weeks have seen Amylyx lose its only marketed product but receive numerous accolades for its decision to voluntarily withdraw Relyvrio a…

2 years, 2 months ago

Short Long
View Episode
It's a Design Problem: Women and Clinical Trials
It's a Design Problem: Women and Clinical Trials

Last month, President Biden signed an Executive Order on Advancing Women’s Health Research and Innovation, signalling the significance of women's hea…

2 years, 2 months ago

Short Long
View Episode
Alphabet Soup: AACR and ACC Dominate Headlines This Week
Alphabet Soup: AACR and ACC Dominate Headlines This Week

Conference season is in full swing, with the American Association for Cancer Research and American College of Cardiology concurrently holding their a…

2 years, 3 months ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us